Page last updated: 2024-11-02

pamidronate and Hyperparathyroidism, Primary

pamidronate has been researched along with Hyperparathyroidism, Primary in 4 studies

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"Glucocorticoids may be used as primary treatment when hypercalcemia is due to excessive intestinal calcium absorption (vitamin D intoxication, granulomatous disorders, some lymphomas)."2.82Hypercalcemia: A Review. ( Shane, E; Walker, MD, 2022)
"Primary hyperparathyroidism is characterised by high parathyroid hormone (PTH) levels and concomitant hypercalcaemia."1.40Exceptional localisation of an ectopic parathyroid adenoma at the level of the hyoid bone. ( Musters, L; Smit, C; van Ginhoven, TM, 2014)
"Primary hyperparathyroidism is characterized by hypercalcemia with loss of bone mass."1.33Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. ( Kuo, SW; Lee, IT; Pei, D; Sheu, WH; Tu, ST, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Walker, MD1
Shane, E1
Rigg, J1
Gilbertson, E1
Barrett, HL1
Britten, FL1
Lust, K1
Musters, L1
van Ginhoven, TM1
Smit, C1
Lee, IT1
Sheu, WH1
Tu, ST1
Kuo, SW1
Pei, D1

Reviews

1 review available for pamidronate and Hyperparathyroidism, Primary

ArticleYear
Hypercalcemia: A Review.
    JAMA, 2022, 10-25, Volume: 328, Issue:16

    Topics: Calcium; Coma; COVID-19; Dehydration; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism, Primary

2022

Other Studies

3 other studies available for pamidronate and Hyperparathyroidism, Primary

ArticleYear
Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015.
    The Journal of clinical endocrinology and metabolism, 2019, 03-01, Volume: 104, Issue:3

    Topics: Adult; Antihypertensive Agents; Calcium; Female; Humans; Hyperparathyroidism, Primary; Infant, Newbo

2019
Exceptional localisation of an ectopic parathyroid adenoma at the level of the hyoid bone.
    BMJ case reports, 2014, Jun-11, Volume: 2014

    Topics: Adenoma; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hyoid Bone; Hypercalcemia

2014
Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.
    Journal of bone and mineral metabolism, 2006, Volume: 24, Issue:3

    Topics: Adult; Aged; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hyperparathyroidism, Primary;

2006